• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Acid secretion inhibition with new mechanisms of action: substituted benzimidazole].

作者信息

Olbe L, Lind T, Carlsson E, Cederberg C, Helander H, Wallmark B

出版信息

Schweiz Med Wochenschr. 1984 May 19;114(20):683-5.

PMID:6740286
Abstract

Omeprazole and other substituted benzimidazoles produce a marked inhibition of gastric acid secretion with a long duration of action. Any kind of stimulated acid secretion is inhibited by the substituted benzimidazoles. The inhibitory mechanism of action is very selective. The substituted benzimidazoles inhibit the parietal cell H+, K+-ATPase, an enzyme which is the proton pump in the secretory membrane of the parietal cell. An oral daily dose of 15 mg omeprazole in humans produced about 80% acid inhibition just after dosage and about 40% 24 hours later. Preliminary results in duodenal ulcer patients show that a daily dose of 20-60 mg omeprazole produces fast ulcer healing in almost all patients.

摘要

相似文献

1
[Acid secretion inhibition with new mechanisms of action: substituted benzimidazole].
Schweiz Med Wochenschr. 1984 May 19;114(20):683-5.
2
The mechanism of action of omeprazole--a survey of its inhibitory actions in vitro.奥美拉唑的作用机制——对其体外抑制作用的综述
Scand J Gastroenterol Suppl. 1985;108:37-51.
3
Effects of IY-81149, a newly developed proton pump inhibitor, on gastric acid secretion in vitro and in vivo.新型质子泵抑制剂IY-81149对体外和体内胃酸分泌的影响。
Arzneimittelforschung. 2001;51(3):204-13. doi: 10.1055/s-0031-1300026.
4
Omeprazole. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome.奥美拉唑。对其药效学和药代动力学特性以及在消化性溃疡疾病和佐林格-埃利森综合征中的治疗潜力的初步综述。
Drugs. 1986 Jul;32(1):15-47. doi: 10.2165/00003495-198632010-00002.
5
[Inhibition of H+/K+-ATPase in the parietal cell with omeprazole: a new principle of gastric acid inhibition].[奥美拉唑对壁细胞H⁺/K⁺-ATP酶的抑制作用:胃酸抑制的新原理]
Ned Tijdschr Geneeskd. 1985 Apr 13;129(15):679-82.
6
Effects of single and repeated doses of omeprazole on gastric acid and pepsin secretion in man.单次及重复剂量奥美拉唑对人体胃酸和胃蛋白酶分泌的影响。
Gut. 1984 Jul;25(7):707-10. doi: 10.1136/gut.25.7.707.
7
Treatment of acid-peptic diseases by inhibition of gastric H+,K+-ATPase.通过抑制胃H⁺,K⁺-ATP酶治疗酸相关性疾病。
Annu Rev Med. 1986;37:97-105. doi: 10.1146/annurev.me.37.020186.000525.
8
[Behavior of acid secretion under the long-term daily administration of omeprazol].[长期每日服用奥美拉唑时胃酸分泌的情况]
Schweiz Med Wochenschr. 1983 Jun 18;113(24):895-8.
9
[Effects of gastric proton pump inhibitors on gastric secretion and peptic ulcers].[胃质子泵抑制剂对胃酸分泌及消化性溃疡的影响]
Nihon Yakurigaku Zasshi. 1986 Apr;87(4):351-60. doi: 10.1254/fpj.87.351.
10
[Discovery and development of the proton pump inhibitor].[质子泵抑制剂的发现与研发]
Nihon Rinsho. 1992 Jan;50(1):11-7.